Crystallinity of Dynasan ®114 and Dynasan ®118 matrices for the production of stable Miglyol ®-loaded nanoparticles

Journal of Thermal Analysis and Calorimetry

Volumn 108, Issue 1, 2012, Pages 101-108

  Severino, Patrícia ^a,b   Pinho, Samantha C ^c   Souto, Eliana B ^b,d   Santana, Maria H A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

Author keywords

Differential scanning calorimetry; Dynasan 114; Dynasan 118; Lipid nanoparticles; Miglyol 812; Miglyol 840; Polarized light microscopy; Wide angle X ray diffraction

Indexed keywords

CRYSTALLINITIES; DIFFERENTIAL SCANNING CALORIMETRIES (DSC); HIGH PRESSURE HOMOGENIZATION; LIPID NANOPARTICLES; LONG TERM STABILITY; MEAN SIZE; NANOSTRUCTURED LIPID CARRIERS; PHYSICO-CHEMICAL CHARACTERIZATION; POLYDISPERSITY INDICES; PROPYLENE GLYCOLS; SOLID LIPID NANOPARTICLE (SLN); WIDE ANGLE XRAY DIFFRACTION;

LIGHT POLARIZATION; LIPIDS; NANOPARTICLES; X RAY DIFFRACTION; ZETA POTENTIAL;

DIFFERENTIAL SCANNING CALORIMETRY;

EID: 84858070958     PISSN: 13886150     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10973-011-1613-7     Document Type: Article

References (30)

1. Sahoo SK, Parveen S, Panda JJ. The present and future of nanotechnology in human health care. Nanomedicine. 2007. doi: 10.1016/j.nano.2006.11.008. (Pubitemid 46428187)
2. Aji Alex MR, Chacko AJ, Jose S, Souto EB. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur J Pharm Sci. 2011. doi: 10.1016/j.ejps.2010.10.002.
3. Gonzalez-Mira E, Egea MA, Garcia ML, Souto EB. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids Surf B Biointerfaces. 2010. doi: 10.1016/j.colsurfb.2010.07.029.
4. Heney M, Alipour M, Vergidis D, Omri A, Mugabe C, Th'ng J, Suntres Z. Effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells. Can J Physiol Pharmacol. 2010. doi: 10.1139/y10-097.
5. Wang J, Liu W, Tu Q, Song N, Zhang Y, Nie N. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery. Biomacromolecules. 2011. doi: 10.1021/bm101206g.
6. Barata TS, Shaunak S, Teo I, Zloh M, Brocchini S. Structural studies of biologically active glycosylated polyamidoamine (PAMAM) dendrimers. J Mol Model. 2010. doi: 10.1007/s00894-010-0907-1.
7. Rawat MK, Jain A, Singh S. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats. J Pharm Sci. 2011. doi: 10.1002/jps.22454.
8. Souto EB, Muller RH. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes. Handb Exp Pharmacol. 2010. doi: 10.1007/978-3-642- 00477-3-4.
9. RH Muller K Mader S Gohla 2000 Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art Eur J Pharm Biopharm 50 1 161 177 10.1016/S0939-6411(00)00087-4 1:CAS:528:DC%2BD3cXjslyisrg%3D (Pubitemid 30326695)
10. De Oliveira GG, Ferraz HG, Severino P, Souto EB. Analysis of phase transition and dehydration processes of nevirapine. J Therm Anal Calorim. 2011. doi: 10.1007/s10973-011-1424-x.
11. Yoshid MI, Oliveira MA, Gomes ECL, Mussel WN, Castro WV, Soares CDV. Thermal characterization of lovastatin in pharmaceutical formulations. J Therm Anal Calorim. 2011. doi: 10.1007/s10973-011-1510-0.
12. Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mader K. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release. 2004. doi: 10.1016/j.jconrel.2003.11.012. (Pubitemid 38230037)
13. Bondi ML, Craparo EF, Giammona G, Drago F. Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution. Nanomedicine (Lond). 2009. doi: 10.2217/nnm.09.67.
14. Souto EB, Muller RH. Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization. J Microencapsul. 2006. doi: 10.1080/02652040500435295. (Pubitemid 44132547)
15. Ali H, Shirode AB, Sylvester PW, Nazzal S. Preparation, characterization, and anticancer effects of simvastatin-tocotrienol lipid nanoparticles. Int J Pharm. 2010. doi: 10.1016/j.ijpharm.2010.01.018.
16. Wissing SA, Kayser O, Muller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 2004. doi: 10.1016/j.addr.2003.12.002. (Pubitemid 38510473)
17. Muchow M, Maincent P, Muller RH. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm. 2008. doi: 10.1080/03639040802130061.
18. W Mehnert K Mader 2001 Solid lipid nanoparticles: production, characterization and applications Adv Drug Deliv Rev 47 165 196 10.1016/S0169-409X(01)00105-3 1:CAS:528:DC%2BD3MXislGls7g%3D (Pubitemid 32324113)
19. A Lippacher RH Muller K Mader 2001 Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles Int J Pharm 214 9 12 10.1016/S0378-5173(00)00623-2 1:CAS:528:DC%2BD3MXitFWgs78%3D (Pubitemid 32244069)
20. RH Muller M Radtke SA Wissing 2002 Nanostructured lipid matrices for improved microencapsulation of drugs Int J Pharm 242 121 128 10.1016/S0378-5173(02)00180-1 1:CAS:528:DC%2BD38Xmt1ygu70%3D
21. RH Muller M Radtke SA Wissing 2002 Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv Drug Deliv Rev 54 S131 S155 10.1016/S0169-409X(02)00118-7 1:CAS:528:DC%2BD38XpsVOhtrc%3D (Pubitemid 35379959)
22. Souto EB, Mehnert W, Muller RH. Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC. J Microencapsul. 2006. doi: 10.1080/02652040600612439. (Pubitemid 44132550)
23. Potta SG, Minemi S, Nukala RK, Peinado C, Lamprou DA, Urquhart A, Douroumis D. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility. J Microencapsul. 2011. doi: 10.3109/02652048.2010.529948.
24. Luykx DM, Peters RJ, van Ruth SM, Bouwmeester H. A review of analytical methods for the identification and characterization of nano delivery systems in food. J Agric Food Chem. 2008. doi: 10.1021/jf8013926.
25. Rica RA, Jiménez ML, Delgado AV. Dynamic mobility of rodlike goethite particles. Langmuir. 2009. doi: 10.1021/la9013976.
26. V Jenning AF Thunemann SH Gohla 2000 Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids Int J Pharm 199 167 177 10.1016/S0378-5173(00)00378-1 1:CAS:528:DC%2BD3cXjtVWqsrc%3D (Pubitemid 30236188)
27. Mezzena M, Scalia S, Young PM, Traini D. Solid lipid budesonide microparticles for controlled release inhalation therapy. AAPS J. 2009. doi: 10.1208/s12248-009-9148-6.
28. Kim JK, Park JS, Kim CK. Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release. Int J Pharm. 2010. doi: 10.1016/j.ijpharm.2009.09.008.
29. Attama AA, Muller-Goymann CC. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid. Int J Pharm. 2007. doi: 10.1016/j.ijpharm.2006.10.032. (Pubitemid 46400318)
30. Bayindir ZS, Yuksel N. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci. 2010. doi: 10.1002/jps.21944.